Book chapters

Elsevier,

3D Printing in Podiatric Medicine, Volume , 1 January 2022

This content aligns with Goal 3: Good Health and Wellbeing and Goal 10: Reduced Inequalities by highlighting the types of human podiatry disabilities and correction methods using traditional, 3DP technology and its challenges.
Elsevier,

Managing Treatment-Resistant Depression: Road to Novel Therapeutics, Volume , 1 January 2022

This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by reviewing the data on clinical and epidemiological predictors of antidepressant response, or predictors of treatment-resistant depression and discussing the possible prognostic value of clinical features, like severity, chronicity, subtypes of depression, comorbidities, history of trauma, and epidemiological features like gender, age, sociodemographic status.
Elsevier,

Herbal Medicines: A Boon for Healthy Human Life, Volume , 1 January 2022

This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by exploring herbal medicines role in depression to provide alternatives to current psychiatric drugs which may cause many induced side effects.
Elsevier,

Artificial Intelligence, Machine Learning, and Mental Health in Pandemics: A Computational Approach, Volume , 1 January 2022

This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by presenting the design, execution, and test results of the dyslexia health management system; and highlighting the high potential for worldwide deployment using blockchain technology.
Elsevier,

The Neuroscience of Autism, Volume , 1 January 2022

This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by examining the history and evolution of the definition and characterization of autism over the past several decades and the impact of it on how the disorder is perceived by autistic individuals, families, and professionals
Elsevier,

Epigenetics of Stress and Stress Disorders, Volume , 1 January 2022

This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by examining Pharmacoepigenetics as an emerging field and the relation of epigenetic mechanisms to treatment response to inform treatment selection.
Elsevier,

Managing Treatment-Resistant Depression: Road to Novel Therapeutics, Volume , 1 January 2022

This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by reviewing the evidence base for treatment of youth with depression, with a focus on management of treatment-resistant depression.
Elsevier,

Biomedical Engineering Applications for People with Disabilities and the Elderly in the COVID-19 Pandemic and Beyond, Volume , 1 January 2022

This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by examining the impact of the COVID-19 pandemic on the physical and mental health of the elderly.
Elsevier,

The Neuroscience of Autism, Volume , 1 January 2022

This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by providing different levels and magnitude of explanation for the various behavioral symptoms seen in individuals with ASD, collectively providing a comprehensive picture of this disorder.
Elsevier,

Progress in Brain Research
Volume 268, Issue 1, 2022, Pages 191-215

This content links with Goal 3: Good health and well-being and Goal 10: Reduced Inequalities by providing information about pituitary adenomas and the complex collection of disorders they produce.

Pages